BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Oceaneering
OII
$2.43B
| $89.5K | ﹤0.01% |
25,422
+16,865
| +197% | +$59.4K |
|
2427
Viking Therapeutics
VKTX
$2.79B
| $89.3K | ﹤0.01% |
15,339
+5,740
| +60% | +$33.4K |
|
|
CLDT
2428
Chatham Lodging
CLDT
$348M
| $88.9K | ﹤0.01% |
11,663
+6,980
| +149% | +$53.2K |
|
|
MTL
2429
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $88.8K | ﹤0.01% |
58,802
+45,160
| +331% | +$68.2K |
|
2430
Liberty Latin America Class A
LILA
$1.5B
| $88.7K | ﹤0.01% |
10,754
+8,132
| +310% | +$67.1K |
|
2431
i3 Verticals
IIIV
$724M
| $88.6K | ﹤0.01% |
3,507
+2,788
| +388% | +$70.4K |
|
2432
UroGen Pharma
URGN
$869M
| $88.5K | ﹤0.01% |
4,588
+3,521
| +330% | +$67.9K |
|
2433
Bank of Marin Bancorp
BMRC
$398M
| $88.5K | ﹤0.01% |
3,056
+2,565
| +522% | +$74.3K |
|
2434
First Mid Bancshares
FMBH
$945M
| $88.5K | ﹤0.01% |
3,547
+2,838
| +400% | +$70.8K |
|
2435
Comtech Telecommunications
CMTL
$69.1M
| $88.4K | ﹤0.01% |
6,315
+4,887
| +342% | +$68.4K |
|
|
CATC
2436
DELISTED
CAMBRIDGE BANCORP
CATC
| $88.2K | ﹤0.01% |
1,659
+1,120
| +208% | +$59.5K |
|
2437
Transmedics
TMDX
$3.91B
| $88.2K | ﹤0.01% |
6,397
+5,612
| +715% | +$77.3K |
|
2438
Fidelity MSCI Utilities Index ETF
FUTY
$1.98B
| $88.1K | ﹤0.01% |
2,323
+746
| +47% | +$28.3K |
|
2439
Hyster-Yale Materials Handling
HY
$634M
| $87.9K | ﹤0.01% |
2,366
+1,741
| +279% | +$64.7K |
|
2440
Helix Energy Solutions
HLX
$914M
| $87.8K | ﹤0.01% |
36,440
+23,992
| +193% | +$57.8K |
|
2441
Dillards
DDS
$8.97B
| $87.7K | ﹤0.01% |
2,402
-511
| -18% | -$18.7K |
|
|
SPNE
2442
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $87.5K | ﹤0.01% |
6,122
+5,079
| +487% | +$72.6K |
|
2443
SPDR S&P Pharmaceuticals ETF
XPH
$184M
| $87K | ﹤0.01% |
2,000
| – | – |
|
2444
POSCO
PKX
$15.3B
| $86.9K | ﹤0.01% |
2,076
+45
| +2% | +$1.88K |
|
2445
BioLife Solutions
BLFS
$1.22B
| $86.5K | ﹤0.01% |
2,990
+2,785
| +1,359% | +$80.6K |
|
|
KBAL
2446
DELISTED
Kimball International
KBAL
| $86.2K | ﹤0.01% |
8,183
+6,861
| +519% | +$72.3K |
|
2447
SIGA Technologies
SIGA
$639M
| $86K | ﹤0.01% |
12,517
+9,667
| +339% | +$66.4K |
|
2448
Carriage Services
CSV
$670M
| $85.8K | ﹤0.01% |
3,847
+3,232
| +526% | +$72.1K |
|
2449
Shoe Carnival
SCVL
$636M
| $85.7K | ﹤0.01% |
5,104
+3,482
| +215% | +$58.5K |
|
2450
Akebia Therapeutics
AKBA
$782M
| $85.3K | ﹤0.01% |
33,995
+22,661
| +200% | +$56.9K |
|